Management of Male Infertility with Poor Sperm Morphology (1-2%)
For couples where the male partner has moderate to good motility and count but poor morphology (1-2%), intrauterine insemination (IUI) remains a viable treatment option and should not be excluded based on morphology alone.
Impact of Poor Morphology on Treatment Approach
- Poor sperm morphology (1-2%) alone should not exclude couples from attempting IUI when other parameters (motility and count) are adequate 1
- There appears to be no clinical difference in IUI pregnancy success among men with normal and abnormal sperm morphology when total motile sperm count and female age are favorable 1
- Current guidelines do not recommend either for or against the use of IUI in couples with solely poor sperm quality in the male partner 2
Recommended Treatment Algorithm
Initial Assessment:
Treatment Protocol:
Evidence on Morphology and IUI Success
- Studies show that when TMSC is adequate (>5 million), poor morphology (<30%) may be compensated by the quantity of motile sperm 3
- A systematic review of 41,018 IUI cycles found no statistical or clinical differences in pregnancy rates between men with normal (>4%) and abnormal (≤4%) morphology 1
- Even with very poor morphology (<1%), pregnancy rates per IUI cycle were comparable (14.0% vs 13.9%) to those with morphology ≥1% 1
Important Considerations and Caveats
- Sperm motility appears to be a more significant determinant of IUI success than morphology 4
- If TMSC is <5 million combined with poor morphology (<30%), success rates decrease significantly (5.43% vs 18.42% when TMSC ≥5 million) 3
- For couples with failed IUI attempts, progression to IVF with ICSI should be considered as the next step 2, 5
- There is no established threshold for sperm parameters below which IUI should be withheld, making it difficult to exclude patients based solely on morphology 2
Alternative Approaches
- For couples with severe oligoasthenoteratozoospermia (OAT) syndrome where all parameters are poor, IVF with ICSI may be more appropriate as the first-line treatment 5, 6
- Medical interventions such as FSH analogues may be considered to improve sperm parameters before attempting IUI, though evidence is limited 2, 5
- Avoid testosterone monotherapy as it suppresses spermatogenesis and should not be prescribed for men interested in fertility 2